1.
The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study. Radiol Oncol [Internet]. 2024 Sep. 9 [cited 2026 Nov. 21];58(3):335-47. Available from: https://www.radioloncol.com/index.php/ro/article/view/4413